Friehling TD, Marinchak RA, Kowey PR. Role of permanent pacemakers in the pharmacologic therapy of patients with reentrant tachyarrhythmias.
Pacing Clin Electrophysiol 1988;
11:83-92. [PMID:
2449676 DOI:
10.1111/j.1540-8159.1988.tb03931.x]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Improved pacemaker technology has permitted application in more diverse groups of patients. A more recently described subset appears to be those with reentrant tachycardias treatable with antiarrhythmic drugs. Here, pacing offers the ability both to test the efficacy of a drug regimen and to provide adjunctive "fail-safe" therapy for those with episodic breakthrough. With the advent of more sophisticated devices, especially those with cardioversion/defibrillation capability, we anticipate a growing interest in these applications which will undoubtedly benefit patients.
Collapse